Santanna Birdlong v. BioLife Plasma Services LP

CourtDistrict Court, W.D. Louisiana
DecidedNovember 24, 2025
Docket6:25-cv-00635
StatusUnknown

This text of Santanna Birdlong v. BioLife Plasma Services LP (Santanna Birdlong v. BioLife Plasma Services LP) is published on Counsel Stack Legal Research, covering District Court, W.D. Louisiana primary law. Counsel Stack provides free access to over 12 million legal documents including statutes, case law, regulations, and constitutions.

Bluebook
Santanna Birdlong v. BioLife Plasma Services LP, (W.D. La. 2025).

Opinion

UNITED STATES DISTRICT COURT WESTERN DISTRICT OF LOUISIANA LAFAYETTE DIVISION

SANTANNA BIRDLONG CASE NO. 6:25-CV-00635

VERSUS JUDGE DAVID C. JOSEPH

BIOLIFE PLASMA SERVICES LP MAGISTRATE JUDGE CAROL B. WHITEHURST

REPORT AND RECOMMENDATION

Before the Court is BioLife Plasma Services, LLC’s (“BioLife”) Motion to Dismiss pursuant to Rule 12(b)(6). (Rec. Doc. 11). Plaintiff failed to file an opposition to the Motion. The Motion was referred to the undersigned magistrate judge for review, report, and recommendation in accordance with the provisions of 28 U.S.C. § 636 and the standing orders of this Court. Considering the evidence, the law, and the arguments, or lack thereof, of the parties, and for the reasons fully explained below, it is RECOMMENDED that BioLife’s Motion to Dismiss, while not without merit, be DENIED WITHOUT PREJUDICE at this time. Factual Background Plaintiff, a current employee of BioLife, filed a charge with the Equal Employment Opportunity Commission (“EEOC”) against BioLife on February 18, 2025. (Rec. Docs. 1, 11-1, p. 8, & 11-3). Plaintiff received a “right to sue” letter; however, no specifics or dates were given. (Rec. Doc. 1, ¶ 19). Plaintiff initiated the present action on May 9, 2025, pursuant to Title VII of the Civil Rights Act of 1964 seeking damages and injunctive relief alleging discrimination and retaliation.

(Rec. Doc. 1). On August 29, 2025, BioLife filed the Motion to Dismiss (Rec. Doc. 11) presently before the Court. According to the Complaint, BioLife is “a plasma donation company with

several centers across the [United States] that “allows qualified donors to donate plasma and receive compensation.” (Rec. Doc. 1, ¶ 4). Plaintiff alleges an internal investigation was launched at BioLife’s Lafayette, Louisiana location on July 20, 2024, after she made a report to the company’s Ethics Reporting Helpline regarding

“deletion and/or destruction of pertinent donor records” by Medical Support Specialists (“MSS”) in violation of the company’s standard operating procedures (“SOP”). (Rec. Doc. 1, ¶ 6). Plaintiff says she made this report after her reports to

the Center Manager and Center Quality Manager were disregarded. (Id.). On July 24, 2024, Plaintiff notified the Center Quality Manager that one MSS was bullying another MSS and Plaintiff was concerned she would “be the next target to be bullied” because she “refused to engage in the malice acts with the MSS accused of bullying.”

(Id. at ¶ 7). Per Plaintiff, no corrective action was taken in response to her report. (Id.). On September 25, 2024, Plaintiff was called in to meet with the Center Manager and Center Quality Manager to discuss her work productivity where she

was informed that more than one MSS complained about her not completing certain tasks on September 19, 2024. (Id. at ¶ 8). Plaintiff alleges she was able to prove that she worked her entire shift and informed them that this was an example of the

previously reported bullying. (Id.) Again, no corrective action was taken. (Rec. Doc. 1, ¶ 8). Following this meeting, Plaintiff alleges that the Center Manager and Center Quality Manager “cleared a possibly mentally unstable donor to donate.” (Id. at ¶

9). Plaintiff alleges they refused to listen to her when she suggested that the donor likely needed a reassessment to ensure no risk to his safety or others who receive plasma derived therapies. (Id.). Per Plaintiff, the donor was cleared to continue

donating without any corrective actions taken. (Id.). On September 28, 2024, Plaintiff says she reported acts of bullying from an MSS to the Center Manager. (Id. at ¶ 11). Plaintiff says “[t]his caused an exacerbation of [her] mental health symptoms resulting in [her] need to leave work

early. No reprimand was issued to this MSS, and the MSS was granted approval to leave work early on said date leaving the center understaffed causing a hardship on the company and the donor’s wait time in the center.” (Id.). On or around October 2, 2024, all available MSSs attended a mandatory quarterly meeting. (Rec. Doc. 1, ¶ 12). Per Plaintiff, the possibly mentally unstable

donor who was cleared to donate was discussed, and Plaintiff again questioned this decision. (Id.). According to Plaintiff, on October 25, 2024, she experienced a panic attack but was unable to call out due to the procedure for calling out. (Id. at ¶ 13).

After arriving at work, Plaintiff was issued an Employee Conference Memorandum (“ECM”) for “misconduct in the [October 2, 2024] mandatory meeting…” (Id.). Plaintiff signed the form but noted that she did not agree with it and informed the Center Manager that she “felt as thought [she] was being discriminated and retaliated

against due to the several illegal and unethical issues [she] reported.” (Id.). In the days after receiving the ECM, Plaintiff questioned it and reported additional bullying by an MSS, but not corrective action was taken. (Id. at ¶ 15).

Plaintiff alleges that she was finally forced to apply for “several different leave types within the company’s leave platform” due to her steady decline in mental health. (Rec. Doc. 1, ¶ 16). The Center Manager “refused to allow [Plaintiff] the specified time off” due to staffing shortages. (Id.). Over the next several weeks,

Plaintiff says she had several conversations with the Center Manager regarding ongoing bullying and the ECM, but alleges she was not supplied “an answer to any of [her] questions.” (Id. at ¶ 17). Plaintiff has since received clearance from her

medical provider for medical leave “[a]fter months of enduring a decline in [her] mental health status and [the Center Manager] denying [her] requested time off.” (Id. at ¶ 18).

Plaintiff believes the Center Manager “has shown various acts of favoritism” towards other MSSs and fears that the Center Manager “is making attempts to keep [her] quiet about reporting pertinent information…” (Id. at ¶ 20). Plaintiff contends

all of these actions, and/or inactions, constitute discrimination and retaliation under Title VII. (Rec. Doc. 1). Applicable Law I. Leniency for Pro Se Litigants

Plaintiff is not represented by counsel. The pleadings of pro se litigants are held to a more lenient standard than those of attorneys and are construed liberally to prevent a loss of rights that might result from inartful expression. Taylor v. Books A Million, Inc., 296 F.3d 376, 378 (5th Cir. 2002); Cledera v. United States, 834 Fed.

App’x 969, 972 (5th Cir. 2021) (citing Andrade v. Gonzales, 459 F.3d 538, 543 (5th Cir. 2006)). However, pro se plaintiffs are required to plead factual allegations that rise above a speculative level, and courts should not create causes of action where

none exist. Chhim v. University of Texas at Austin, 836 F.3d 467, 469 (5th Cir. 2016); see also, Taylor v. Books A Million, Inc., 296 F.3d at 378; Cledera v. United States, 834 Fed. App’x at 972). A pro se litigant should ordinarily be offered an opportunity

to amend his complaint before it is dismissed but leave to amend is not required if an amendment would be futile, or if, in other words, an amended complaint would still fail to survive a Rule 12(b)(6) motion to dismiss. Mendoza-Tarango v. Flores,

982 F.3d 395, 402 (5th Cir. 2020); Marucci Sports, L.L.C. v. NCAA, 751 F.3d 368, 378 (5th Cir. 2014). Furthermore, pro se litigants have “no license to harass others, clog the judicial machinery with meritless litigation, and abuse already overloaded court dockets.” Farguson v.

Free access — add to your briefcase to read the full text and ask questions with AI

Related

Baker v. Putnal
75 F.3d 190 (Fifth Circuit, 1996)
Collins v. Morgan Stanley Dean Witter
224 F.3d 496 (Fifth Circuit, 2000)
Taylor v. Books a Million, Inc.
296 F.3d 376 (Fifth Circuit, 2002)
Andrade v. Gonzales
459 F.3d 538 (Fifth Circuit, 2006)
Southern Scrap Material Co. v. Abc Insurance
541 F.3d 584 (Fifth Circuit, 2008)
Lormand v. US Unwired, Inc.
565 F.3d 228 (Fifth Circuit, 2009)
Brewster v. Dretke
587 F.3d 764 (Fifth Circuit, 2009)
Papasan v. Allain
478 U.S. 265 (Supreme Court, 1986)
Bell Atlantic Corp. v. Twombly
550 U.S. 544 (Supreme Court, 2007)
Ashcroft v. Iqbal
556 U.S. 662 (Supreme Court, 2009)
Edward M. Farguson v. Mbank Houston, N.A.
808 F.2d 358 (Fifth Circuit, 1986)
Willie C. Free v. United States
879 F.2d 1535 (Seventh Circuit, 1989)
Carol Vaughn v. Woodforest Bank
665 F.3d 632 (Fifth Circuit, 2011)

Cite This Page — Counsel Stack

Bluebook (online)
Santanna Birdlong v. BioLife Plasma Services LP, Counsel Stack Legal Research, https://law.counselstack.com/opinion/santanna-birdlong-v-biolife-plasma-services-lp-lawd-2025.